NeutriSci and Lexaria Bioscience Enter Global Licensing Agreement
Feb 26, 2018 13:30 pm UTC| Business
VANCOUVER, British Columbia , Feb. 26, 2018 -- – via NetworkWire - NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX-V:NU) (OTCQB:NRXCF) (Frankfurt:1N9) and Lexaria Bioscience Corp. (“Lexaria”)...
Core-Mark Announces Fourth Quarter 2017 Investor Call
Feb 26, 2018 13:30 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Feb. 26, 2018 -- Core-Mark Holding Company, Inc. (NASDAQ:CORE), announced today that it will release its earnings before the market opens on Thursday March 1, 2018 for the fourth quarter...
Consorteum Holdings, Inc. Announces Joint Business Agreement with DevLex Ltd.
Feb 26, 2018 13:30 pm UTC| Business
ATLANTA, Feb. 26, 2018 -- via NetworkWire – Consorteum Holdings, Inc. ("Consorteum" or the "Company") (OTCPK:CSRH), a software development company and mobile device solutions provider, today announced that its wholly...
Feb 26, 2018 13:30 pm UTC| Business
CHICAGO, Feb. 26, 2018 -- Innovator Capital Management, LLC (Innovator) today announced plans to celebrate their partnership with Investor’s Business Daily® (IBD®) on the Innovator IBD® ETF Leaders ETF (LDRS) and...
Amyris to Announce Fourth Quarter and Fiscal Year 2017 Financial Results on Thursday, March 15, 2018
Feb 26, 2018 13:30 pm UTC| Business
EMERYVILLE, Calif., Feb. 26, 2018 -- Amyris, Inc. (Nasdaq:AMRS) will report financial results for the fourth quarter and fiscal year ended December 31, 2017 after market close on Thursday, March 15, 2018. The company...
Vyome Biosciences Announces Launch of Dermatology Products Through Exclusive Partnership
Feb 26, 2018 13:30 pm UTC| Business
Vyome Partners with a Large, Global Specialty Pharmaceutical Company to Market its Dandruff Products NEW DELHI, India, Feb. 26, 2018 -- Vyome Biosciences, a clinical-stage specialty pharmaceutical company developing...
Hemispherx To Supply Ampligen for Pancreatic Cancer Patients in Canada Under Special Access Program
Feb 26, 2018 13:30 pm UTC| Business
ORLANDO, Fla., Feb. 26, 2018 -- Hemispherx Biopharma, Inc. (NYSE American:HEB) said it is expanding its partnership with myTomorrows to supply Ampligen® for pancreatic cancer patients in Canada under a Special Access...
U.S. payrolls exceeded expectations significantly, while the unemployment rate dropps to 4.1%.
Hyundai’s $7.6B EV Metaplant Unleashes 2025 IONIQ 5 with Tesla Charging and Huge Federal Tax Credit!